corporate profile 2020 - takeda-chc.co.jp · "main" company. the current dakiyama symbol...

5
CORPORATE PROFILE 2020 Takeda Consumer Healthcare Company Limited

Upload: others

Post on 29-Sep-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CORPORATE PROFILE 2020 - takeda-chc.co.jp · "main" company. The current Dakiyama symbol is an updated and modernized version created in 1961 to celebrate the 180th anniversary of

CORPORATE PROFILE2020

Takeda Consumer Healthcare Company Limited

Page 2: CORPORATE PROFILE 2020 - takeda-chc.co.jp · "main" company. The current Dakiyama symbol is an updated and modernized version created in 1961 to celebrate the 180th anniversary of

2 3

CORPORATE PHILOSOPHY

Mission

The mission of Takeda Consumer Healthcare is to continue to contribute

to the extension of healthy life expectancy by delivering “excellent

products and timely, accurate information” to our customers who want to

“live healthy”.

In the Japanese market, we will continue to nurture and

protect core brands such as Alinamin and Benza. We will enter

new fields, including Rx-to-OTC switching, general use testing

kits, health foods, and medicinal cosmetics. These fields will

comprise a substantial part of our portfolio by 2020.

Starting with Asia, we will pursue business opportunities

overseas. We will develop a base of customers for products

such as Alinamin and Hicee, and secure a lasting increase in

market share in foreign markets. We will establish in Asia the

same positive brand value we have created in Japan.

Our industry is constantly changing, and so are the health and

beauty needs of our customers. We will always stay alert to

new needs, even those that customers themselves are not yet

aware of. We will swiftly provide products that match these

needs ahead of our competitors.

To make this happen, every part of our organization will work

together to the best of our ability in a common cause. We will

endeavor to reward employees that share our sense of mission.

We will create an environment in which all of our people,

regardless of department, organization, or country, are able to

face the challenges of the future without fear of failure.

Our AmbitionRejoicing in the Universal Needfor a Healthier, More Active Life.

Our OrganizationStriving Together with a Sense ofUrgency to Create New Value

VisionOur BusinessPioneering New Fields in Japan and New Markets in Asia

People want to live healthy, active lives. They want to enjoy

good health for as many years as possible. As a consumer

healthcare business unit, it is our duty to help them achieve this.

We will fully utilize our medical knowledge and experience,

which has been built up over our long history, to provide high-

quality products for personal care and self-medication, including

products that offer preventative care and light treatment.

We turn dreams into reality. With our help, people will stay

healthy longer, and enjoy more from life. They can devote

themselves to work or hobbies, travel to places they always

wanted to visit, eat good food, and spend more time with

friends and family.

Takeda Consumer Healthcare Company Limited was built

on the universal values of Takeda-ism. Guided by these

principles, we will always be by the side of our customers,

taking joy in contributing to their well-being.

PRESIDENT’S MESSAGE

Our mission at Takeda Consumer Healthcare is to continue

to contribute to the extension of healthy life expectancy

by delivering our brand of excellent products and reliable

information to people who want to enjoy long-lasting health

and lead active lives.

While Japan has the highest life expectancy in the world,

the country is also facing the issue of a rapidly declining

population due to a falling birth rate and an aging society.

By 2025, all the post-war baby boomers will have turned 75

and, in 2040, the number of elderly people will peak as the

following generation reaches the age of 65.

According to estimates of social security benefit costs,

medical expenses in 2040 will increase from the current 40

trillion yen to approximately 70 trillion yen, while the working

population (15 to 64-year-olds) is expected to decrease by

about 17%.

In this context, extending healthy life expectancy is an urgent

issue for Japan, and the government has set a goal to extend

them by at least three years by 2040.

By using the knowledge and experience in pharmaceuticals

we have accumulated in the 239 years since the founding of

Takeda Pharmaceutical, we strive to support people's health

in realms such as self-care and self-medication through our

brand of excellent products and reliable information.

Our growth strategy is based on the customer-first perspective

that comes from our vision. In addition, all of our divisions

will work together effectively to develop initiatives focused

on the following four strategic themes that are pivotal to our

growth:

As a member of the Takeda Group, we at Takeda Consumer

Healthcare will continue to remain faithful to our Brand

Promise through contributing to people's health by continuing

to deliver excellent products and reliable information.

Mari NogamiPresident

When it comes to supporting your health,we're committed to putting you first

1. Developing Alinamin and Benza into megabrands while

cultivating our basic brands

2. Incorporating Rx-to-OTC switch drugs

3. Rebuilding our online operations

4. Growing our Chinese operations, including by appealing

to tourists

Page 3: CORPORATE PROFILE 2020 - takeda-chc.co.jp · "main" company. The current Dakiyama symbol is an updated and modernized version created in 1961 to celebrate the 180th anniversary of

4 5

Chobei Takeda I established the medicine

brokerage that later became Takeda

Pharmaceutical Co., Ltd.

Company name changed to Takeda

Pharmaceutical Co., Ltd.

“Alinamin®” launched as Japan's first vitamin B1

derivative

General cold drug “Benza®” launched

Consumer Health Headquarters established

within the Pharmaceutical Division

“Alinamin® V” drink launched

The Healthcare Headquarters becomes

independent of the Pharmaceutical Division and

is newly established as the Healthcare Division

With the restructuring of the global business

management system, Japan Consumer

Healthcare Business Unit (JCHBU) established

Change in ownership following the absorption-

type split of Takeda's JCHBU business, and

Takeda Consumer Healthcare Co., Ltd.

established (started business on April 1, 2017)

Aluminum pouch drink “Alinamin® Medical

Balance” launched

June 12, 1781

1943

1954

1955

1985

1987

1990

2015

April 15, 2016

2019

HISTORY

Our corporate brand symbol, known as Dakiyama, originates

from Takeda's first brand symbol, Dakiyama Hon, which was

used when Chobei Takeda’s first store was established in 1781.

Chobei established his business under the Omiya brand

that had employed him as an apprentice. Omiya was known

by the original Dakiyama symbol, the outer frame of which

depicts two mountains, one on top and one inverted below,

representing the mountain that Chobei would have to cross

twice when traveling from his hometown of Omi (now Shiga

Prefecture) to his business base in Osaka, and back home

Takeda's Corporate Brand Symbol: Dakiyama (Embracing Mountains)

again. Chobei adopted this symbol and incorporated his

family’s kanji character (hon), meaning "true" or "main" in

Japanese, placing it in the center of the Dakiyama. It is said

that he did this as a mark of respect toward his own family

that had supported him - although another theory is that it

represented his ambition for his own business to become the

"main" company. The current Dakiyama symbol is an updated

and modernized version created in 1961 to celebrate the

180th anniversary of the founding of Takeda.

CORPORATE CULTURE

Our workforce as of 2019

Item Status

Takeda Consumer Healthcare Company is made up of diverse

employees who work with a sense of purpose to realize the

company's vision. We believe in providing our employees

with opportunities for growth and allowing them to fulfil their

potential and feel passionate about their careers, regardless

of age, gender, work style, or nationality. As a company

committed to helping people enjoy healthy lives, we actively

promote flexible approaches to work, and strive to create

an environment where employees can have a good work-life

balance and live rich, healthy lives themselves.

Promoting Diversity

At Takeda Consumer Healthcare, we are making various efforts

to create a working environment that makes employees feel

valued, based on the idea that each employee’s motivation

leads to a highly productive work-style.

Our vision is to have flexible work and leave systems that

adapt to necessary changes in work-styles, encouraging

effective communication and collaboration across all layers of

the organization.

Promotion of Work-style Reforms

Female: 18.9 years Male: 17.9 years

29.7%

73.7%

Flextime system

Remote work system

Average number of years at the company

Percentage of female employees

Rate of annual paid holidays taken (permanent staff)

Use of flexible work systems 95.8%

70.5%

First-generation ALINAMIN sugar-coated tablets*This product is discontinued

Page 4: CORPORATE PROFILE 2020 - takeda-chc.co.jp · "main" company. The current Dakiyama symbol is an updated and modernized version created in 1961 to celebrate the 180th anniversary of

6 7

OUR PRODUCTS

In 1950 Takeda released Panvitan®, Japan's first multivitamin,

and in 1954 it successfully developed Alinamin®, a vitamin

derivative drug that increases absorption of vitamin B1.

Takeda Consumer Healthcare Company (TCHC) started from

a desire to help people suffering from malnutrition caused by

the post-war food shortages.

Caring about people's health is where Takeda Consumer Healthcare Company started. We are always there for our customers.

Our major business partners and products

Amato Pharmaceutical

Products, Ltd.

Senju Pharmaceutical

Co., Ltd.

Johnson & Johnson K.K. Nihon Pharmaceutical

Co., Ltd.

Borraginol series

(drugs for hemorrhoids)

Nicorette series (stop-smoking aids)

Aneton series (antitussives and

expectorants, rhinitis medicine)

Terra-cortril NANKO a

(dermatological medicine)

Terramycin NANKO a

(dermatological medicine)

Tylenol A (antipyretic analgesic)

Mytear series

(eye drops, contact lens solutions)

Osvan series (Bactericidal disinfectant)

We have a strong, unshakable belief in helping people achieve

healthy lives by providing excellent products and reliable

information. We take our role in consumer healthcare very

seriously and are working to quickly respond to our customer's

diverse needs, and growing the company.

ABOUT TAKEDA

Headquartered in Japan, Takeda Pharmaceutical Co., Ltd.

is an R&D-driven global biopharmaceutical leader whose

values are based on placing our patients as central to the

basic spirit of our organization. We work to help improve

the quality of life for patients in approximately 80 countries

and regions.

Subsidiary

Takeda Healthcare Products Co., Ltd.

2-21 Osadano-cho, Fukuchiyama,

Kyoto, 620-0853, Japan

TEL: 0773-27-5421

FAX: 0773-27-5489

Parent Company

Takeda Pharmaceutical Co., Ltd.

Takeda Global Headquarters

1-1, Nihonbashi-Honcho 2-Chome,

Chuo-ku, Tokyo, 103-8668, Japan

TEL: 03-3278-2 1 1 1

FAX: 03-3278-2000

www.takeda.com

Takeda Healthcare Products Co., Ltd. was established in

1980 as the leading manufacturer of OTC drugs marketed by

Takeda Consumer Healthcare Co., Ltd.

Page 5: CORPORATE PROFILE 2020 - takeda-chc.co.jp · "main" company. The current Dakiyama symbol is an updated and modernized version created in 1961 to celebrate the 180th anniversary of

JAPANCHINA

COMPANY FACTS

Company Name Takeda Consumer Healthcare Company Limited

Date EstablishedApril 15, 2016

Business Started April 1, 2017

Director/AuditorChairman of the Board (part-time) Milano Furuta

President Mari Nogami

Director (part-time) Tetsuya Kuwayama

Auditor (part-time) Eiji Suzuki

Capital490 million yen

Scope of Business Research & development, manufacturing, sales and

marketing of over-the-counter products, quasi-drugs,

and more.

OfficesTotal of 8 offices

Fiscal Year End March 31

ShareholderTakeda Pharmaceutical Company Limited (100%)

Tekko Building 23F

8-2 Marunouchi 1-chome, Chiyoda-ku,

Tokyo 100-0005, Japan

TEL: +81-3-6212-8501

FAX: +81-3-6212-8695

www.takeda-chc.co.jp/en/

August 2020

OFFICES

Head OfficeTekko Building 23F

8-2 Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-0005

Osaka OfficeTakeda Midosuji Building

1-1 Doshomachi 4-Chome, Chuo-ku, Osaka 541-0045

Sapporo Office4 Kitaichijo-Nishi 13-chome, Chuo-ku, Sapporo 060-0001,

Hokkaido

Sendai Office18-21 Honcho 2-chome, Aoba-ku, Sendai 980-0014

Nagoya OfficeNagoya Center Building 7F

2-13 Nishiki 2-chome, Naka-ku, Nagoya 460-0003

Hiroshima OfficeTakeda Hiroshima Building 2F

1-25 Komachi, Naka-ku, Hiroshima 730-0041

Fukuoka OfficeFukuoka Takeda Building 4F

9-12 Shimokawabata, Hatata-ku, Fukuoka 812-0027

Juso CMC Center17-85 Jusohonmachi, 2-chome, Yodogawa-ku, Osaka 532-0024

Oversea OfficeTakeda Pharmaceutical (China) Company Limited29 Floor, Wheelock Square No.1717,

West Nanjing Road, Shanghai 200040

TEL: +86-21-2230-6867 FAX: +86-21-2230-6889

Takeda Consumer Healthcare Company Limited